A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design

BACKGROUND: Neoadjuvant radiochemotherapy (RCT) is now part of the armamentarium of cancer of the lower and middle rectum. It is recommended in current clinical practice prior to surgical excision if the lesion is classified T3/T4 or N+. Histological complete response, defined by the absence of pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefevre, Jérémie H, Rousseau, Alexandra, Svrcek, Magali, Parc, Yann, Simon, Tabassome, Tiret, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848646/
https://www.ncbi.nlm.nih.gov/pubmed/24028546
http://dx.doi.org/10.1186/1471-2407-13-417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848646/
https://www.ncbi.nlm.nih.gov/pubmed/24028546
http://dx.doi.org/10.1186/1471-2407-13-417

Ejemplares similares